FBAFX | SBACX | FBAFX / SBACX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 26 years | - |
Gain YTD | 14.250 | 11.875 | 120% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 236B | 956M | 24,686% |
Annual Yield % from dividends | 2.47 | 0.56 | 442% |
Returns for 1 year | 24.73 | 20.24 | 122% |
Returns for 3 years | 17.24 | 10.21 | 169% |
Returns for 5 years | N/A | 25.71 | - |
Returns for 10 years | N/A | 44.17 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BOCT | 42.40 | 0.10 | +0.24% |
Innovator U.S. Equity Buffer ETF™ Oct | |||
XJUL | 34.80 | -0.01 | -0.04% |
FT Cboe Vest U.S. Eq Enh & ModBufETF-Jul | |||
EQAL | 48.22 | -0.16 | -0.33% |
Invesco Russell 1000 Equal Weight ETF | |||
IXN | 81.46 | -0.53 | -0.65% |
iShares Global Tech ETF | |||
HELX | 32.97 | -0.45 | -1.35% |
Franklin Genomic Advancements ETF |